HER2(ヒト上皮増殖因子受容体2)阻害剤のグローバル市場2024-2028:単剤療法、併用療法

【英語タイトル】Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market 2024-2028

Technavioが出版した調査資料(IRTNTR72960-23)・商品コード:IRTNTR72960-23
・発行会社(調査会社):Technavio
・発行日:2023年10月11日
・ページ数:約120
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:北米、ヨーロッパ、アジア、その他地域
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥380,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥608,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

HER2(ヒト上皮成長因子受容体2)阻害剤の世界市場 2024〜2028年HER2(ヒト上皮成長因子受容体2)阻害剤市場は、2023年から2028年にかけて1億1,066.53億米ドルの成長が予測され、予測期間中のCAGRは9.94%で加速すると予測されています。当レポートでは、HER2(ヒト上皮細胞増殖因子受容体2)阻害剤市場について、市場規模や予測、動向、成長促進要因、課題などの全体的な分析に加え、約25のベンダーを網羅したベンダー分析も掲載しています。
当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供します。乳癌と胃癌の高い有病率、研究開発の進歩、乳癌に対する意識の高まりが市場を牽引しています。

Technavio社のHER2(ヒト上皮成長因子受容体2)阻害剤市場は以下のように分類されます。
製品別
- 単剤療法
- 併用療法

流通チャネル別
- 小売薬局
- 病院薬局
- オンライン薬局

地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域(ROW)

本調査では、今後数年間におけるHER2(ヒト上皮成長因子受容体2)阻害剤市場の成長を促進する主な理由の一つとして、患者支援プログラムを挙げています。また、乳がんに対する新しい診断法の導入や戦略的提携は、市場の大きな需要につながるでしょう。

本レポートでは、HER2(ヒト上皮成長因子受容体2)阻害剤市場について、以下の領域をカバーしています。
- HER2(ヒト上皮成長因子受容体2)阻害剤市場規模
- HER2(ヒト上皮成長因子受容体2)阻害剤市場予測
- HER2(ヒト上皮増殖因子受容体2)阻害剤市場の産業分析

HER2(ヒト上皮成長因子受容体2)阻害剤市場の主要ベンダーであるAmgen Inc、 Boehringer Ingelheim International GmbH、Bristol Myers Squibb Co.、Dr Reddys Laboratories Ltd.、Eli Lilly and Co.、F. Hoffmann La Roche Ltd.、Intas Pharmaceuticals Ltd.、JSC BIOCAD、MacroGenics Inc.、Merck KGaA、Novartis AG、Pfizer Inc.、Puma Biotechnology Inc.、Samsung Biologics Co. Ltd.、Shanghai Henlius Biotech Inc.、Viatris Inc.、Celltrion Healthcare Co. Ltd.などを分析しています。また、HER2(ヒト上皮成長因子受容体2)阻害剤市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。当レポートでは、主要ベンダーの分析に加え、包括的な市場とベンダーの状況を掲載しています。
当調査会社は、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、総括する方法で、市場の詳細な姿を提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

1 エグゼクティブサマリー
2 市場状況
3 市場規模
4 過去の市場規模
5 ファイブフォース分析
6 HER2(ヒト上皮増殖因子受容体2)阻害剤の世界市場:製品別市場分析
7 HER2(ヒト上皮増殖因子受容体2)阻害剤の世界市場:流通チャネル別市場分析
8 顧客状況
9 地域別状況
10 推進要因・課題・動向
11 企業状況
12 企業分析
13 付録

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global – Market size and forecast 2023-2028 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2023-2028 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global HER2 (human epidermal growth factor receptor 2) inhibitors market 2018 – 2022
o Exhibit 18: Historic Market Size – Data Table on global her2 (human epidermal growth factor receptor 2) inhibitors market 2018 – 2022 ($ million)
o 4.2 Product Segment Analysis 2018 – 2022
o Exhibit 19: Historic Market Size – Product Segment 2018 – 2022 ($ million)
o 4.3 Distribution Channel Segment Analysis 2018 – 2022
o Exhibit 20: Historic Market Size – Distribution Channel Segment 2018 – 2022 ($ million)
o 4.4 Geography Segment Analysis 2018 – 2022
o Exhibit 21: Historic Market Size – Geography Segment 2018 – 2022 ($ million)
o 4.5 Country Segment Analysis 2018 – 2022
o Exhibit 22: Historic Market Size – Country Segment 2018 – 2022 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2023 and 2028
• 6 Market Segmentation by Product
o 6.1 Market segments
o Exhibit 30: Chart on Product – Market share 2023-2028 (%)
o Exhibit 31: Data Table on Product – Market share 2023-2028 (%)
o 6.2 Comparison by Product
o Exhibit 32: Chart on Comparison by Product
o Exhibit 33: Data Table on Comparison by Product
o 6.3 Monotherapy – Market size and forecast 2023-2028
o Exhibit 34: Chart on Monotherapy – Market size and forecast 2023-2028 ($ million)
o Exhibit 35: Data Table on Monotherapy – Market size and forecast 2023-2028 ($ million)
o Exhibit 36: Chart on Monotherapy – Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Monotherapy – Year-over-year growth 2023-2028 (%)
o 6.4 Combination therapy – Market size and forecast 2023-2028
o Exhibit 38: Chart on Combination therapy – Market size and forecast 2023-2028 ($ million)
o Exhibit 39: Data Table on Combination therapy – Market size and forecast 2023-2028 ($ million)
o Exhibit 40: Chart on Combination therapy – Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Combination therapy – Year-over-year growth 2023-2028 (%)
o 6.5 Market opportunity by Product
o Exhibit 42: Market opportunity by Product ($ million)
o Exhibit 43: Data Table on Market opportunity by Product ($ million)
• 7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Exhibit 44: Chart on Distribution Channel – Market share 2023-2028 (%)
o Exhibit 45: Data Table on Distribution Channel – Market share 2023-2028 (%)
o 7.2 Comparison by Distribution Channel
o Exhibit 46: Chart on Comparison by Distribution Channel
o Exhibit 47: Data Table on Comparison by Distribution Channel
o 7.3 Retail pharmacies – Market size and forecast 2023-2028
o Exhibit 48: Chart on Retail pharmacies – Market size and forecast 2023-2028 ($ million)
o Exhibit 49: Data Table on Retail pharmacies – Market size and forecast 2023-2028 ($ million)
o Exhibit 50: Chart on Retail pharmacies – Year-over-year growth 2023-2028 (%)
o Exhibit 51: Data Table on Retail pharmacies – Year-over-year growth 2023-2028 (%)
o 7.4 Hospital pharmacies – Market size and forecast 2023-2028
o Exhibit 52: Chart on Hospital pharmacies – Market size and forecast 2023-2028 ($ million)
o Exhibit 53: Data Table on Hospital pharmacies – Market size and forecast 2023-2028 ($ million)
o Exhibit 54: Chart on Hospital pharmacies – Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on Hospital pharmacies – Year-over-year growth 2023-2028 (%)
o 7.5 Online pharmacies – Market size and forecast 2023-2028
o Exhibit 56: Chart on Online pharmacies – Market size and forecast 2023-2028 ($ million)
o Exhibit 57: Data Table on Online pharmacies – Market size and forecast 2023-2028 ($ million)
o Exhibit 58: Chart on Online pharmacies – Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on Online pharmacies – Year-over-year growth 2023-2028 (%)
o 7.6 Market opportunity by Distribution Channel
o Exhibit 60: Market opportunity by Distribution Channel ($ million)
o Exhibit 61: Data Table on Market opportunity by Distribution Channel ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2023-2028
o Exhibit 67: Chart on North America – Market size and forecast 2023-2028 ($ million)
o Exhibit 68: Data Table on North America – Market size and forecast 2023-2028 ($ million)
o Exhibit 69: Chart on North America – Year-over-year growth 2023-2028 (%)
o Exhibit 70: Data Table on North America – Year-over-year growth 2023-2028 (%)
o 9.4 Europe – Market size and forecast 2023-2028
o Exhibit 71: Chart on Europe – Market size and forecast 2023-2028 ($ million)
o Exhibit 72: Data Table on Europe – Market size and forecast 2023-2028 ($ million)
o Exhibit 73: Chart on Europe – Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on Europe – Year-over-year growth 2023-2028 (%)
o 9.5 Asia – Market size and forecast 2023-2028
o Exhibit 75: Chart on Asia – Market size and forecast 2023-2028 ($ million)
o Exhibit 76: Data Table on Asia – Market size and forecast 2023-2028 ($ million)
o Exhibit 77: Chart on Asia – Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Asia – Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2023-2028
o Exhibit 79: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
o Exhibit 80: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
o Exhibit 81: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o 9.7 US – Market size and forecast 2023-2028
o Exhibit 83: Chart on US – Market size and forecast 2023-2028 ($ million)
o Exhibit 84: Data Table on US – Market size and forecast 2023-2028 ($ million)
o Exhibit 85: Chart on US – Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on US – Year-over-year growth 2023-2028 (%)
o 9.8 Germany – Market size and forecast 2023-2028
o Exhibit 87: Chart on Germany – Market size and forecast 2023-2028 ($ million)
o Exhibit 88: Data Table on Germany – Market size and forecast 2023-2028 ($ million)
o Exhibit 89: Chart on Germany – Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on Germany – Year-over-year growth 2023-2028 (%)
o 9.9 UK – Market size and forecast 2023-2028
o Exhibit 91: Chart on UK – Market size and forecast 2023-2028 ($ million)
o Exhibit 92: Data Table on UK – Market size and forecast 2023-2028 ($ million)
o Exhibit 93: Chart on UK – Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on UK – Year-over-year growth 2023-2028 (%)
o 9.10 China – Market size and forecast 2023-2028
o Exhibit 95: Chart on China – Market size and forecast 2023-2028 ($ million)
o Exhibit 96: Data Table on China – Market size and forecast 2023-2028 ($ million)
o Exhibit 97: Chart on China – Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on China – Year-over-year growth 2023-2028 (%)
o 9.11 Canada – Market size and forecast 2023-2028
o Exhibit 99: Chart on Canada – Market size and forecast 2023-2028 ($ million)
o Exhibit 100: Data Table on Canada – Market size and forecast 2023-2028 ($ million)
o Exhibit 101: Chart on Canada – Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on Canada – Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 103: Market opportunity By Geographical Landscape ($ million)
o Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 Amgen Inc.
o Exhibit 111: Amgen Inc. – Overview
o Exhibit 112: Amgen Inc. – Product / Service
o Exhibit 113: Amgen Inc. – Key offerings
o 12.4 AstraZeneca Plc
o Exhibit 114: AstraZeneca Plc – Overview
o Exhibit 115: AstraZeneca Plc – Product / Service
o Exhibit 116: AstraZeneca Plc – Key news
o Exhibit 117: AstraZeneca Plc – Key offerings
o 12.5 Biocon Ltd.
o Exhibit 118: Biocon Ltd. – Overview
o Exhibit 119: Biocon Ltd. – Business segments
o Exhibit 120: Biocon Ltd. – Key offerings
o Exhibit 121: Biocon Ltd. – Segment focus
o 12.6 Boehringer Ingelheim International GmbH
o Exhibit 122: Boehringer Ingelheim International GmbH – Overview
o Exhibit 123: Boehringer Ingelheim International GmbH – Business segments
o Exhibit 124: Boehringer Ingelheim International GmbH – Key news
o Exhibit 125: Boehringer Ingelheim International GmbH – Key offerings
o Exhibit 126: Boehringer Ingelheim International GmbH – Segment focus
o 12.7 Bristol Myers Squibb Co.
o Exhibit 127: Bristol Myers Squibb Co. – Overview
o Exhibit 128: Bristol Myers Squibb Co. – Product / Service
o Exhibit 129: Bristol Myers Squibb Co. – Key news
o Exhibit 130: Bristol Myers Squibb Co. – Key offerings
o 12.8 Celltrion Healthcare Co. Ltd.
o Exhibit 131: Celltrion Healthcare Co. Ltd. – Overview
o Exhibit 132: Celltrion Healthcare Co. Ltd. – Product / Service
o Exhibit 133: Celltrion Healthcare Co. Ltd. – Key offerings
o 12.9 Dr Reddys Laboratories Ltd.
o Exhibit 134: Dr Reddys Laboratories Ltd. – Overview
o Exhibit 135: Dr Reddys Laboratories Ltd. – Business segments
o Exhibit 136: Dr Reddys Laboratories Ltd. – Key offerings
o Exhibit 137: Dr Reddys Laboratories Ltd. – Segment focus
o 12.10 Eli Lilly and Co.
o Exhibit 138: Eli Lilly and Co. – Overview
o Exhibit 139: Eli Lilly and Co. – Product / Service
o Exhibit 140: Eli Lilly and Co. – Key news
o Exhibit 141: Eli Lilly and Co. – Key offerings
o 12.11 F. Hoffmann La Roche Ltd.
o Exhibit 142: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 143: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 144: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 145: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 146: F. Hoffmann La Roche Ltd. – Segment focus
o 12.12 Intas Pharmaceuticals Ltd.
o Exhibit 147: Intas Pharmaceuticals Ltd. – Overview
o Exhibit 148: Intas Pharmaceuticals Ltd. – Product / Service
o Exhibit 149: Intas Pharmaceuticals Ltd. – Key offerings
o 12.13 Merck KGaA
o Exhibit 150: Merck KGaA – Overview
o Exhibit 151: Merck KGaA – Business segments
o Exhibit 152: Merck KGaA – Key news
o Exhibit 153: Merck KGaA – Key offerings
o Exhibit 154: Merck KGaA – Segment focus
o 12.14 Novartis AG
o Exhibit 155: Novartis AG – Overview
o Exhibit 156: Novartis AG – Business segments
o Exhibit 157: Novartis AG – Key offerings
o Exhibit 158: Novartis AG – Segment focus
o 12.15 Pfizer Inc.
o Exhibit 159: Pfizer Inc. – Overview
o Exhibit 160: Pfizer Inc. – Product / Service
o Exhibit 161: Pfizer Inc. – Key news
o Exhibit 162: Pfizer Inc. – Key offerings
o 12.16 Puma Biotechnology Inc.
o Exhibit 163: Puma Biotechnology Inc. – Overview
o Exhibit 164: Puma Biotechnology Inc. – Product / Service
o Exhibit 165: Puma Biotechnology Inc. – Key offerings
o 12.17 Viatris Inc.
o Exhibit 166: Viatris Inc. – Overview
o Exhibit 167: Viatris Inc. – Business segments
o Exhibit 168: Viatris Inc. – Key news
o Exhibit 169: Viatris Inc. – Key offerings
o Exhibit 170: Viatris Inc. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 171: Inclusions checklist
o Exhibit 172: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 173: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 174: Research methodology
o Exhibit 175: Validation techniques employed for market sizing
o Exhibit 176: Information sources
o 13.5 List of abbreviations
o Exhibit 177: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Product
Exhibits6: Executive Summary – Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size – Data Table on global her2 (human epidermal growth factor receptor 2) inhibitors market 2018 – 2022 ($ million)
Exhibits19: Historic Market Size – Product Segment 2018 – 2022 ($ million)
Exhibits20: Historic Market Size – Distribution Channel Segment 2018 – 2022 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2018 – 2022 ($ million)
Exhibits22: Historic Market Size – Country Segment 2018 – 2022 ($ million)
Exhibits23: Five forces analysis – Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants – Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes – Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry – Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition – Five forces 2023 and 2028
Exhibits30: Chart on Product – Market share 2023-2028 (%)
Exhibits31: Data Table on Product – Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Monotherapy – Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Monotherapy – Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Monotherapy – Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Monotherapy – Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Combination therapy – Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Combination therapy – Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Combination therapy – Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Combination therapy – Year-over-year growth 2023-2028 (%)
Exhibits42: Market opportunity by Product ($ million)
Exhibits43: Data Table on Market opportunity by Product ($ million)
Exhibits44: Chart on Distribution Channel – Market share 2023-2028 (%)
Exhibits45: Data Table on Distribution Channel – Market share 2023-2028 (%)
Exhibits46: Chart on Comparison by Distribution Channel
Exhibits47: Data Table on Comparison by Distribution Channel
Exhibits48: Chart on Retail pharmacies – Market size and forecast 2023-2028 ($ million)
Exhibits49: Data Table on Retail pharmacies – Market size and forecast 2023-2028 ($ million)
Exhibits50: Chart on Retail pharmacies – Year-over-year growth 2023-2028 (%)
Exhibits51: Data Table on Retail pharmacies – Year-over-year growth 2023-2028 (%)
Exhibits52: Chart on Hospital pharmacies – Market size and forecast 2023-2028 ($ million)
Exhibits53: Data Table on Hospital pharmacies – Market size and forecast 2023-2028 ($ million)
Exhibits54: Chart on Hospital pharmacies – Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Hospital pharmacies – Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Online pharmacies – Market size and forecast 2023-2028 ($ million)
Exhibits57: Data Table on Online pharmacies – Market size and forecast 2023-2028 ($ million)
Exhibits58: Chart on Online pharmacies – Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Online pharmacies – Year-over-year growth 2023-2028 (%)
Exhibits60: Market opportunity by Distribution Channel ($ million)
Exhibits61: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America – Market size and forecast 2023-2028 ($ million)
Exhibits68: Data Table on North America – Market size and forecast 2023-2028 ($ million)
Exhibits69: Chart on North America – Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on North America – Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Europe – Market size and forecast 2023-2028 ($ million)
Exhibits72: Data Table on Europe – Market size and forecast 2023-2028 ($ million)
Exhibits73: Chart on Europe – Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Europe – Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Asia – Market size and forecast 2023-2028 ($ million)
Exhibits76: Data Table on Asia – Market size and forecast 2023-2028 ($ million)
Exhibits77: Chart on Asia – Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Asia – Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
Exhibits80: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
Exhibits81: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on US – Market size and forecast 2023-2028 ($ million)
Exhibits84: Data Table on US – Market size and forecast 2023-2028 ($ million)
Exhibits85: Chart on US – Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on US – Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Germany – Market size and forecast 2023-2028 ($ million)
Exhibits88: Data Table on Germany – Market size and forecast 2023-2028 ($ million)
Exhibits89: Chart on Germany – Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Germany – Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on UK – Market size and forecast 2023-2028 ($ million)
Exhibits92: Data Table on UK – Market size and forecast 2023-2028 ($ million)
Exhibits93: Chart on UK – Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on UK – Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on China – Market size and forecast 2023-2028 ($ million)
Exhibits96: Data Table on China – Market size and forecast 2023-2028 ($ million)
Exhibits97: Chart on China – Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on China – Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on Canada – Market size and forecast 2023-2028 ($ million)
Exhibits100: Data Table on Canada – Market size and forecast 2023-2028 ($ million)
Exhibits101: Chart on Canada – Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on Canada – Year-over-year growth 2023-2028 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ million)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits105: Impact of drivers and challenges in 2023 and 2028
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: Amgen Inc. – Overview
Exhibits112: Amgen Inc. – Product / Service
Exhibits113: Amgen Inc. – Key offerings
Exhibits114: AstraZeneca Plc – Overview
Exhibits115: AstraZeneca Plc – Product / Service
Exhibits116: AstraZeneca Plc – Key news
Exhibits117: AstraZeneca Plc – Key offerings
Exhibits118: Biocon Ltd. – Overview
Exhibits119: Biocon Ltd. – Business segments
Exhibits120: Biocon Ltd. – Key offerings
Exhibits121: Biocon Ltd. – Segment focus
Exhibits122: Boehringer Ingelheim International GmbH – Overview
Exhibits123: Boehringer Ingelheim International GmbH – Business segments
Exhibits124: Boehringer Ingelheim International GmbH – Key news
Exhibits125: Boehringer Ingelheim International GmbH – Key offerings
Exhibits126: Boehringer Ingelheim International GmbH – Segment focus
Exhibits127: Bristol Myers Squibb Co. – Overview
Exhibits128: Bristol Myers Squibb Co. – Product / Service
Exhibits129: Bristol Myers Squibb Co. – Key news
Exhibits130: Bristol Myers Squibb Co. – Key offerings
Exhibits131: Celltrion Healthcare Co. Ltd. – Overview
Exhibits132: Celltrion Healthcare Co. Ltd. – Product / Service
Exhibits133: Celltrion Healthcare Co. Ltd. – Key offerings
Exhibits134: Dr Reddys Laboratories Ltd. – Overview
Exhibits135: Dr Reddys Laboratories Ltd. – Business segments
Exhibits136: Dr Reddys Laboratories Ltd. – Key offerings
Exhibits137: Dr Reddys Laboratories Ltd. – Segment focus
Exhibits138: Eli Lilly and Co. – Overview
Exhibits139: Eli Lilly and Co. – Product / Service
Exhibits140: Eli Lilly and Co. – Key news
Exhibits141: Eli Lilly and Co. – Key offerings
Exhibits142: F. Hoffmann La Roche Ltd. – Overview
Exhibits143: F. Hoffmann La Roche Ltd. – Business segments
Exhibits144: F. Hoffmann La Roche Ltd. – Key news
Exhibits145: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits146: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits147: Intas Pharmaceuticals Ltd. – Overview
Exhibits148: Intas Pharmaceuticals Ltd. – Product / Service
Exhibits149: Intas Pharmaceuticals Ltd. – Key offerings
Exhibits150: Merck KGaA – Overview
Exhibits151: Merck KGaA – Business segments
Exhibits152: Merck KGaA – Key news
Exhibits153: Merck KGaA – Key offerings
Exhibits154: Merck KGaA – Segment focus
Exhibits155: Novartis AG – Overview
Exhibits156: Novartis AG – Business segments
Exhibits157: Novartis AG – Key offerings
Exhibits158: Novartis AG – Segment focus
Exhibits159: Pfizer Inc. – Overview
Exhibits160: Pfizer Inc. – Product / Service
Exhibits161: Pfizer Inc. – Key news
Exhibits162: Pfizer Inc. – Key offerings
Exhibits163: Puma Biotechnology Inc. – Overview
Exhibits164: Puma Biotechnology Inc. – Product / Service
Exhibits165: Puma Biotechnology Inc. – Key offerings
Exhibits166: Viatris Inc. – Overview
Exhibits167: Viatris Inc. – Business segments
Exhibits168: Viatris Inc. – Key news
Exhibits169: Viatris Inc. – Key offerings
Exhibits170: Viatris Inc. – Segment focus
Exhibits171: Inclusions checklist
Exhibits172: Exclusions checklist
Exhibits173: Currency conversion rates for US$
Exhibits174: Research methodology
Exhibits175: Validation techniques employed for market sizing
Exhibits176: Information sources
Exhibits177: List of abbreviations



★調査レポート[HER2(ヒト上皮増殖因子受容体2)阻害剤のグローバル市場2024-2028:単剤療法、併用療法] (コード:IRTNTR72960-23)販売に関する免責事項を必ずご確認ください。
★調査レポート[HER2(ヒト上皮増殖因子受容体2)阻害剤のグローバル市場2024-2028:単剤療法、併用療法]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆